AlzChem Group AG (ETR:ACT0)

Germany · Delayed Price · Currency is EUR

165.24

+4.04 (2.51%)

At close: Sep 18, 2026

Market Cap	1.68B +16.3%
Revenue (ttm)	593.80M +5.5%
Net Income	67.77M +17.0%
EPS	6.70 +17.3%
Shares Out	10.12M
PE Ratio	24.72
Forward PE	23.65
Dividend	2.10 (1.27%)
Ex-Dividend Date	May 6, 2026

Volume	8,660
Open	159.00
Previous Close	161.20
Day's Range	159.00 - 169.54
52-Week Range	123.20 - 210.60
Beta	0.39
Analysts	Strong Buy
Price Target	205.81 (+24.55%)
Earnings Date	Oct 29, 2026

About AlzChem Group AG

AlzChem Group AG, together with its subsidiaries, develops, produces, and markets a range of chemical specialties in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The Specialty Chemicals segment sells specialty chemical products that are used in the chemical, food, animal feed, defence technology, and renewable energies industries. This segment manufactures composite materials and adhesives, as well as silico... [Read more]

Industry Chemicals and Allied Products

Founded 1908

Employees 1,794

Stock Exchange Deutsche Börse Xetra

Ticker Symbol ACT0

Full Company Profile

Financial Performance

In 2025, AlzChem Group AG's revenue was 575.05 million, an increase of 2.06% compared to the previous year's 563.44 million. Earnings were 63.46 million, an increase of 17.35%.

Financial Statements

Analyst Summary

According to 8 analysts, the average rating for ACT0 stock is "Strong Buy." The 12-month stock price target is €205.81, which is an increase of 24.55% from the latest price.

Price Target

€205.81

(24.55% upside)

Analyst Consensus: Strong Buy

Stock Forecasts